__timestamp | Merck & Co., Inc. | Travere Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 11606000000 | 59644696 |
Thursday, January 1, 2015 | 10313000000 | 79541000 |
Friday, January 1, 2016 | 9762000000 | 98015000 |
Sunday, January 1, 2017 | 9830000000 | 103958000 |
Monday, January 1, 2018 | 10102000000 | 103654000 |
Tuesday, January 1, 2019 | 10615000000 | 128951000 |
Wednesday, January 1, 2020 | 8955000000 | 135799000 |
Friday, January 1, 2021 | 9634000000 | 149883000 |
Saturday, January 1, 2022 | 10042000000 | 220206000 |
Sunday, January 1, 2023 | 10504000000 | 265542000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, operational efficiency is key. Over the past decade, Merck & Co., Inc. and Travere Therapeutics, Inc. have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. Merck, a giant in the industry, consistently reported SG&A expenses averaging around $10 billion annually, with a notable peak in 2014. In contrast, Travere Therapeutics, a smaller player, saw its SG&A expenses grow by over 340% from 2014 to 2023, reflecting its aggressive expansion strategy.
While Merck's expenses remained relatively stable, Travere's increase highlights its commitment to growth and market penetration. This comparison underscores the diverse strategies employed by pharmaceutical companies to manage operational costs while striving for innovation and market leadership. As the industry continues to evolve, these insights provide a glimpse into the financial strategies shaping the future of healthcare.
Novo Nordisk A/S and Travere Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Merck & Co., Inc. vs Amgen Inc.
Merck & Co., Inc. or argenx SE: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Madrigal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Grifols, S.A.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viridian Therapeutics, Inc.
Zoetis Inc. vs Travere Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Travere Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Travere Therapeutics, Inc.
Apellis Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Wave Life Sciences Ltd. and Travere Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Travere Therapeutics, Inc. or Novavax, Inc.